Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slide: 26 of 37

Potential Harms of rhGH Treatment to Patients With CF: Glucose Control and CFRD (1)

One potential harm of rhGH treatment for patients with CF is an elevated risk of CFRD.

CF directly affects the pancreas, and damage to beta cells results in insulin deficiency. Loss of insulin sensitivity may also play a role in the appearance of this complication.

rhGH regulates glucose utilization and insulin sensitivity, so use of this hormone in patients with CF may influence their risk of developing CFRD.